I can’t find the specific study this website cites, but it mentions:

> In a 2-year trial among patients with type 2 diabetes and high cardiovascular risk, patients treated with this drug experienced a great incidence of diabetic retinopathy complications (3% vs 1.8%). The absolute risk was greater in patients with a history of diabetic retinopathy at baseline (8.2%[drug] vs 5.2%[placebo]) than those without (0.7%[drug] vs 0.4%[placebo]).

https://www.drugs.com/sfx/semaglutide-side-effects.html

Would be very interested in knowing the commenter’s diabetes status.